Go Pro

BILL (BILL) Financials

BILL logo
$49.11 -0.05 (-0.10%)
As of 09/4/2026 03:58 PM Eastern
Annual Income Statements for BILL

Annual Income Statements for BILL

This table shows BILL's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-7.20 -7.31 -31 -99 -326 -224 -29 24 -11
Consolidated Net Income / (Loss)
-7.20 -7.31 -31 -99 -326 -224 -29 24 -11
Net Income / (Loss) Continuing Operations
-7.20 -7.31 -31 -99 -326 -224 -29 24 -11
Total Pre-Tax Income
-7.19 -7.47 -31 -139 -331 -223 -26 30 -10
Total Operating Income
-7.82 -9.80 -34 -114 -317 -296 -174 -81 -73
Total Gross Profit
45 78 118 176 497 864 1,056 1,190 1,338
Total Revenue
65 108 158 238 642 1,058 1,290 1,463 1,653
Operating Revenue
65 108 158 238 642 1,058 1,290 1,463 1,653
Total Cost of Revenue
19 30 39 62 145 194 235 272 315
Operating Cost of Revenue
19 30 39 62 145 194 235 272 315
Total Operating Expenses
53 88 153 290 814 1,160 1,230 1,271 1,411
Selling, General & Admin Expense
16 29 53 128 221 249 278 282 299
Marketing Expense
19 30 45 68 307 516 479 544 616
Research & Development Expense
18 29 53 90 220 315 337 340 301
Depreciation Expense
- - 1.14 4.87 46 48 49 33 33
Other Operating Expenses / (Income)
- - - - 20 32 60 73 71
Restructuring Charge
- - - - 0.00 0.00 28 0.00 91
Total Other Income / (Expense), net
0.63 2.33 3.16 -25 -14 73 148 111 63
Other Income / (Expense), net
0.63 2.33 3.16 -25 -14 73 148 111 63
Income Tax Expense
0.01 -0.16 0.05 -41 -4.32 0.81 2.56 6.61 1.11
Basic Earnings per Share
($1.01) ($0.94) ($0.70) ($1.19) ($3.21) ($2.11) ($0.27) $0.23 ($0.11)
Weighted Average Basic Shares Outstanding
7.16M 7.80M 44.11M 82.81M 101.75M 105.98M 106.10M 103.57M 99.92M
Diluted Earnings per Share
($1.01) ($0.94) ($0.70) ($1.19) ($3.21) ($2.11) ($0.27) ($0.07) ($0.11)
Weighted Average Diluted Shares Outstanding
7.16M 7.80M 44.11M 82.81M 101.75M 105.98M 106.10M 103.91M 99.92M
Weighted Average Basic & Diluted Shares Outstanding
7.16M 7.80M 44.11M 82.81M 104.84M 106.61M 106.69M 101.63M 85.28M

Quarterly Income Statements for BILL

This table shows BILL's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-40 32 7.60 8.91 34 -12 -7.07 -2.96 -2.59 13 -18
Consolidated Net Income / (Loss)
-40 32 7.60 8.91 34 -12 -7.07 -2.96 -2.59 13 -18
Net Income / (Loss) Continuing Operations
-40 32 7.60 8.91 34 -12 -7.07 -2.96 -2.59 13 -18
Total Pre-Tax Income
-39 32 7.60 10 34 -10 -3.07 -2.81 -2.07 15 -20
Total Operating Income
-68 -28 -22 -7.70 -22 -29 -22 -21 -18 -0.40 -34
Total Gross Profit
260 268 278 294 296 291 310 319 331 332 356
Total Revenue
318 323 344 358 363 358 383 396 415 407 436
Operating Revenue
318 323 344 358 363 358 383 396 415 407 436
Total Cost of Revenue
58 55 65 65 67 67 74 77 84 75 80
Operating Cost of Revenue
58 55 65 65 67 67 74 77 84 75 80
Total Operating Expenses
328 296 301 301 318 320 332 339 349 332 390
Selling, General & Admin Expense
70 64 25 67 71 74 70 77 79 72 71
Marketing Expense
118 118 124 126 133 137 148 149 155 153 158
Research & Development Expense
86 82 80 79 85 87 90 80 83 74 63
Depreciation Expense
12 12 12 9.01 7.86 7.86 7.91 8.07 8.38 8.48 8.24
Other Operating Expenses / (Income)
16 18 - 21 21 15 16 16 23 19 14
Restructuring Charge
25 2.10 - 0.00 0.00 0.00 - 8.87 0.41 5.04 77
Total Other Income / (Expense), net
29 60 30 18 55 19 19 18 16 15 14
Other Income / (Expense), net
29 60 30 18 55 19 19 18 16 15 14
Income Tax Expense
1.67 0.37 0.00 1.27 0.05 1.29 4.01 0.15 0.52 1.99 -1.55
Basic Earnings per Share
($0.38) $0.30 $0.07 $0.08 $0.33 ($0.11) ($0.07) ($0.03) ($0.03) $0.13 ($0.18)
Weighted Average Basic Shares Outstanding
105.91M 105.44M 106.10M 105.67M 103.10M 102.22M 103.57M 101.92M 100.53M 99.29M 99.92M
Diluted Earnings per Share
($0.38) $0.00 $0.37 $0.08 ($0.06) ($0.11) $0.02 ($0.03) ($0.03) $0.12 ($0.17)
Weighted Average Diluted Shares Outstanding
105.91M 111.18M 106.10M 107.32M 104.48M 102.22M 103.91M 101.92M 100.53M 112.68M 99.92M
Weighted Average Basic & Diluted Shares Outstanding
105.13M 106.14M 106.69M - 101.95M 103.03M 101.63M 100.16M 98.96M 99.60M 85.28M

Annual Cash Flow Statements for BILL

This table details how cash moves in and out of BILL's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents
-100 392 609 217 1,733 682 -873 173 188
Net Cash From Operating Activities
-8.36 -3.95 -4.43 4.62 -18 188 279 351 416
Net Cash From Continuing Operating Activities
-8.36 -3.95 -4.43 4.62 -18 188 279 324 390
Net Income / (Loss) Continuing Operations
-7.20 -7.31 -31 -99 -326 -224 -29 24 -11
Consolidated Net Income / (Loss)
-7.20 -7.31 -31 -99 -326 -224 -29 24 -11
Depreciation Expense
2.31 3.15 3.23 4.44 9.16 11 14 13 22
Amortization Expense
0.00 -1.32 -2.79 39 95 54 41 17 51
Non-Cash Adjustments To Reconcile Net Income
1.22 4.21 19 73 225 355 263 262 281
Changes in Operating Assets and Liabilities, net
-4.70 -2.68 7.44 -13 -20 -8.97 -9.34 7.59 47
Net Cash From Investing Activities
-418 -96 -249 -1,427 -1,127 259 -409 -817 -29
Net Cash From Continuing Investing Activities
-418 -96 -249 -1,427 -1,127 259 -409 -817 -29
Purchase of Property, Plant & Equipment
-2.05 -4.30 -12 -21 -16 -31 -21 -38 -61
Acquisitions
- 0.00 0.00 -556 -144 -29 0.00 -2.87 0.00
Purchase of Investments
-727 -831 -1,089 -2,070 -2,802 -2,750 -3,042 -3,647 -2,658
Sale and/or Maturity of Investments
307 749 852 1,247 1,958 3,300 2,840 2,215 1,791
Other Investing Activities, net
3.69 -10 -0.96 -26 -131 -233 -186 656 900
Net Cash From Financing Activities
326 492 863 1,640 2,879 235 -743 667 -173
Net Cash From Continuing Financing Activities
326 492 863 1,640 2,879 235 -743 667 -173
Repayment of Debt
-3.39 -9.50 0.00 -2.30 -40 0.00 -933 -565 -34
Repurchase of Common Equity
- - - 0.00 0.00 -88 -212 -430 -560
Issuance of Debt
9.50 0.00 2.30 1,129 598 60 45 1,400 150
Issuance of Common Equity
0.00 0.00 534 8.86 1,354 18 16 12 12
Other Financing Activities, net
264 416 327 504 967 245 341 250 260
Cash Interest Paid
0.44 0.87 0.17 0.11 4.87 7.44 13 14 19
Cash Income Taxes Paid
- - - 0.00 0.00 1.27 5.63 6.32 1.11

Quarterly Cash Flow Statements for BILL

This table details how cash moves in and out of BILL's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
220 -1,353 16 -156 626 -650 380 -11 129 -308 378
Net Cash From Operating Activities
80 67 79 89 79 100 84 97 105 103 111
Net Cash From Continuing Operating Activities
80 72 73 89 79 100 84 97 105 103 85
Net Income / (Loss) Continuing Operations
-40 32 7.60 8.91 34 -12 -7.07 -2.96 -2.59 13 -18
Consolidated Net Income / (Loss)
-40 32 7.60 8.91 34 -12 -7.07 -2.96 -2.59 13 -18
Depreciation Expense
3.24 3.21 3.67 3.17 3.51 3.17 3.16 3.84 7.62 5.30 5.25
Amortization Expense
13 9.35 7.62 9.54 10 12 13 14 23 19 -5.05
Non-Cash Adjustments To Reconcile Net Income
82 49 53 73 44 74 71 71 82 68 60
Changes in Operating Assets and Liabilities, net
22 -21 1.04 -5.94 -12 22 4.09 11 -4.94 -2.71 43
Net Cash From Investing Activities
-50 -618 -43 -140 9.84 -644 -44 -109 137 -301 245
Net Cash From Continuing Investing Activities
-50 -618 -43 -140 9.84 -644 -44 -109 137 -301 245
Purchase of Property, Plant & Equipment
-5.12 -3.85 -5.53 -7.06 -7.10 -9.01 -15 -15 -14 -18 -14
Purchase of Investments
-668 -1,301 -641 -820 -772 -1,301 -755 -614 -579 -899 -565
Sale and/or Maturity of Investments
593 675 789 736 737 819 710 573 724 717 -224
Other Investing Activities, net
30 12 -186 -48 55 -154 16 -53 5.85 -101 1,048
Net Cash From Financing Activities
191 -801 -20 -105 538 -106 340 1.10 -113 -110 49
Net Cash From Continuing Financing Activities
191 -801 -20 -105 538 -106 340 1.10 -113 -110 49
Repayment of Debt
- - -222 - - -0.91 -1.72 - - -1.13 1.44
Repurchase of Common Equity
-200 - - -200 -200 - -30 -83 -133 -57 -288
Issuance of Common Equity
- 8.65 - 5.30 - - 6.25 0.00 4.65 - 7.27
Other Financing Activities, net
391 -144 202 90 -100 -105 365 -66 50 -52 328

Annual Balance Sheets for BILL

This table presents BILL's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets
1,526 2,404 5,969 9,256 9,636 9,179 10,064 10,218
Total Current Assets
1,513 2,379 3,606 6,279 6,673 6,315 7,239 7,435
Cash & Equivalents
90 574 510 1,597 1,617 986 1,038 1,031
Restricted Cash
1,329 1,644 2,209 3,143 3,356 3,705 4,044 4,353
Short-Term Investments
72 124 655 1,108 1,043 602 1,180 906
Accounts Receivable
4.40 4.25 18 24 28 28 32 31
Prepaid Expenses
12 27 67 151 170 297 258 302
Other Current Assets
4.80 6.55 147 256 459 697 685 812
Plant, Property, & Equipment, net
6.56 14 49 57 82 88 117 145
Total Noncurrent Assets
6.64 11 2,314 2,920 2,881 2,776 2,709 2,638
Goodwill
- 0.00 1,772 2,363 2,397 2,397 2,397 2,397
Intangible Assets
- 0.00 417 433 361 281 223 162
Other Noncurrent Operating Assets
6.64 11 125 124 123 98 89 79
Total Liabilities & Shareholders' Equity
1,526 2,404 5,969 9,256 9,636 9,179 10,064 10,218
Total Liabilities
1,353 1,693 3,440 5,212 5,550 5,045 6,150 6,688
Total Current Liabilities
1,349 1,677 2,326 3,409 3,753 4,063 4,589 4,925
Short-Term Debt
0.00 - 0.00 75 135 0.00 213 123
Accounts Payable
5.06 3.48 12 9.95 8.52 7.45 16 9.64
Accrued Expenses
6.56 11 72 120 195 300 252 387
Customer Deposits
1,329 1,644 2,209 3,143 3,356 3,705 4,044 4,353
Current Deferred Revenue
3.47 5.89 13 32 26 17 22 19
Current Employee Benefit Liabilities
4.33 12 20 29 33 34 40 33
Total Noncurrent Liabilities
3.23 16 1,114 1,804 1,797 982 1,561 1,763
Long-Term Debt
- 0.00 989 1,698 1,705 914 1,501 1,713
Noncurrent Deferred Revenue
1.79 2.62 2.93 2.16 0.41 4.17 0.29 0.33
Other Noncurrent Operating Liabilities
1.45 14 122 104 91 63 60 49
Total Equity & Noncontrolling Interests
-103 711 2,530 4,044 4,086 4,134 3,914 3,531
Total Preferred & Common Equity
-103 711 2,530 4,044 4,086 4,134 3,914 3,531
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-103 711 2,530 4,044 4,086 4,134 3,914 3,531
Common Stock
15 857 2,777 4,599 4,947 5,233 5,415 5,626
Retained Earnings
-118 -149 -247 -545 -856 -1,097 -1,511 -2,089
Accumulated Other Comprehensive Income / (Loss)
0.33 2.42 -0.10 -10 -4.49 -1.89 10 -6.42
Other Equity Adjustments
- - 0.00 0.00 0.00 0.00 0.00 0.00

Quarterly Balance Sheets for BILL

This table presents BILL's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2022 12/31/2022 3/31/2023 9/30/2024 12/31/2023 3/31/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets
9,253 9,738 9,381 9,045 9,872 9,122 9,674 9,633 10,151 10,126 10,079
Total Current Assets
6,292 6,748 6,405 6,204 6,956 6,228 6,840 6,804 7,330 7,325 7,284
Cash & Equivalents
1,609 1,617 1,591 853 1,580 952 1,566 1,048 1,100 1,095 995
Restricted Cash
3,122 3,474 3,106 3,787 3,655 3,511 3,767 3,657 3,975 4,032 3,999
Short-Term Investments
1,035 1,067 1,073 620 973 837 645 1,125 1,215 1,147 1,179
Accounts Receivable
29 31 34 32 27 30 29 27 32 41 32
Prepaid Expenses
140 179 170 284 205 256 252 241 269 278 260
Other Current Assets
358 381 431 628 517 642 582 706 739 732 819
Plant, Property, & Equipment, net
62 69 77 90 87 87 94 105 129 127 139
Total Noncurrent Assets
2,899 2,921 2,898 2,751 2,830 2,806 2,740 2,724 2,692 2,674 2,657
Goodwill
2,362 2,397 2,397 2,397 2,397 2,397 2,397 2,397 2,397 2,397 2,397
Intangible Assets
413 402 382 265 321 301 253 238 208 192 177
Other Noncurrent Operating Assets
124 122 120 89 112 109 90 89 88 85 83
Total Liabilities & Shareholders' Equity
9,253 9,738 9,381 9,045 9,872 9,122 9,674 9,633 10,151 10,126 10,079
Total Liabilities
5,206 5,654 5,277 5,032 5,921 5,064 5,865 5,762 6,269 6,320 6,276
Total Current Liabilities
3,326 3,731 3,335 4,056 4,118 3,827 4,122 4,018 4,378 4,430 4,386
Short-Term Debt
0.00 0.00 0.00 - 135 0.00 33 33 33 0.00 0.00
Accounts Payable
12 14 9.14 11 8.77 6.82 5.72 9.30 7.00 5.04 7.15
Accrued Expenses
142 182 171 212 268 264 266 263 306 339 326
Customer Deposits
3,122 3,474 3,106 3,787 3,655 3,511 3,767 3,657 3,975 4,032 3,999
Current Deferred Revenue
30 30 28 22 17 18 22 22 21 21 21
Current Employee Benefit Liabilities
21 31 21 23 33 28 29 33 36 33 33
Total Noncurrent Liabilities
1,880 1,923 1,941 976 1,802 1,237 1,743 1,745 1,890 1,889 1,890
Long-Term Debt
1,775 1,814 1,838 915 1,708 1,146 1,678 1,680 1,832 1,834 1,835
Noncurrent Deferred Revenue
2.32 2.01 1.26 0.10 4.17 4.16 0.20 0.25 0.35 0.42 0.38
Other Noncurrent Operating Liabilities
102 107 102 61 90 87 64 65 58 55 55
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,048 4,084 4,104 4,013 3,952 4,059 3,809 3,870 3,883 3,807 3,803
Total Preferred & Common Equity
4,048 4,084 4,104 4,013 3,952 4,059 3,809 3,870 3,883 3,807 3,803
Total Common Equity
4,048 4,084 4,104 4,013 3,952 4,059 3,809 3,870 3,883 3,807 3,803
Common Stock
4,684 4,812 4,887 5,294 5,089 5,165 5,267 5,332 5,465 5,524 5,571
Retained Earnings
-626 -722 -780 -1,290 -1,137 -1,105 -1,458 -1,469 -1,595 -1,731 -1,770
Accumulated Other Comprehensive Income / (Loss)
-10 -6.36 -3.18 9.12 0.24 -1.51 -0.24 7.28 13 14 1.99

Annual Metrics And Ratios for BILL

This table displays calculated financial ratios and metrics derived from BILL's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding
- - - - - - - - 99,596,727.00
DEI Adjusted Shares Outstanding
- - - - - - - - 99,596,727.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - -0.11
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 67.04% 45.45% 51.18% 169.43% 64.88% 21.89% 13.36% 13.03%
EBITDA Growth
0.00% -15.68% -442.96% -214.11% -136.21% 30.63% 117.79% 212.61% 3.53%
EBIT Growth
0.00% -3.97% -315.50% -348.92% -137.32% 32.59% 88.19% 215.54% -133.31%
NOPAT Growth
0.00% -25.41% -248.85% -233.26% -177.99% 6.64% 41.12% 48.26% 18.50%
Net Income Growth
0.00% -1.65% -325.09% -217.52% -230.59% 31.45% 87.09% 182.41% -147.23%
EPS Growth
0.00% 6.93% 25.53% -70.00% -169.75% 34.27% 87.20% 74.07% -57.14%
Operating Cash Flow Growth
0.00% 52.74% -12.18% 204.36% -491.37% 1,137.79% 48.47% 25.78% 18.59%
Free Cash Flow Firm Growth
0.00% 0.00% -77.94% -741.72% 97.55% -225.01% 121.61% 925.75% -27.38%
Invested Capital Growth
0.00% 0.00% -23.77% 108.92% -121.26% -192.29% -170.19% -159.81% -45.55%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 17.89% 23.45% 9.95% 3.84% 0.00% 3.30%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -111.44% 0.69% 26.37% 297.79% 0.00% -34.03%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -108.94% -0.66% 23.69% 46.34% 0.00% -248.35%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -112.99% -4.15% 12.42% 9.92% 0.00% -3,384.34%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -48.77% -15.21% 23.59% 44.83% 0.00% -6,954.27%
EPS Q/Q Growth
0.00% 0.00% 0.00% -376.00% -10.69% 24.10% 65.38% 0.00% -237.50%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 132.41% -277.96% 93.70% -0.62% 1.50% 6.99%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 97.87% 62.37% -75.97% 0.00% -17.15%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 107.66% -284.81% -152.38% -155.56% 0.00% -72.64%
Profitability Metrics
- - - - - - - - -
Gross Margin
70.13% 72.39% 75.16% 74.06% 77.41% 81.67% 81.82% 81.40% 80.93%
EBITDA Margin
-7.51% -5.20% -19.41% -40.34% -35.36% -14.88% 2.17% 5.99% 3.81%
Operating Margin
-12.05% -9.05% -21.70% -47.83% -49.35% -27.94% -13.50% -5.51% -4.44%
EBIT Margin
-11.08% -6.89% -19.69% -58.48% -51.51% -21.06% -2.04% 2.08% -0.61%
Profit (Net Income) Margin
-11.09% -6.75% -19.73% -41.43% -50.84% -21.14% -2.24% 1.63% -0.68%
Tax Burden Percent
100.14% 97.91% 100.17% 70.85% 98.69% 100.36% 109.72% 78.26% 110.96%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 21.74% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% -387.29% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% -384.05% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 377.36% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -4.21% -7.03% -6.09% -9.93% -5.50% -0.70% 0.59% -0.30%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% -1,276.35% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -0.49% -1.58% -3.33% -4.34% -2.36% -0.28% 0.32% -0.10%
Return on Assets (ROA)
0.00% -0.48% -1.58% -2.36% -4.29% -2.37% -0.31% 0.25% -0.11%
Return on Common Equity (ROCE)
0.00% 2.49% -4.83% -6.09% -9.93% -5.50% -0.70% 0.59% -0.30%
Return on Equity Simple (ROE_SIMPLE)
0.00% 7.12% -4.37% -3.90% -8.07% -5.48% -0.70% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-5.47 -6.86 -24 -80 -222 -207 -122 -63 -51
NOPAT Margin
-8.44% -6.33% -15.19% -33.48% -34.55% -19.56% -9.45% -4.31% -3.11%
Net Nonoperating Expense Percent (NNEP)
0.00% -0.06% -0.37% -0.80% -3.24% -0.40% 2.18% 1.95% 0.89%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -1.12% -0.96%
Cost of Revenue to Revenue
29.87% 27.61% 24.84% 25.94% 22.59% 18.33% 18.18% 18.60% 19.07%
SG&A Expenses to Revenue
24.72% 26.95% 33.92% 53.77% 34.43% 23.53% 21.52% 19.28% 18.11%
R&D to Revenue
27.73% 26.69% 33.63% 37.56% 34.24% 29.73% 26.10% 23.25% 18.18%
Operating Expenses to Revenue
82.19% 81.44% 96.86% 121.89% 126.76% 109.62% 95.31% 86.91% 85.37%
Earnings before Interest and Taxes (EBIT)
-7.19 -7.47 -31 -139 -331 -223 -26 30 -10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-4.87 -5.64 -31 -96 -227 -157 28 88 63
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 9.21 6.03 2.83 0.00 1.35 1.22 1.02
Price to Tangible Book Value (P/TBV)
0.00 0.00 9.21 44.80 9.18 0.00 3.84 3.68 3.71
Price to Revenue (P/Rev)
3.33 1.99 41.54 63.97 17.86 0.00 4.33 3.26 2.18
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 200.26 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.50% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 88.40 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 26.68 53.96 11.51 0.00 0.94 0.15 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 43.06 2.48 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.15 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 2,781.04 0.00 0.00 4.33 0.62 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 14.54 0.00 0.00 0.00 37.83 0.67 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.39 0.44 0.45 0.22 0.44 0.52
Long-Term Debt to Equity
0.00 0.00 0.00 0.39 0.42 0.42 0.22 0.38 0.49
Financial Leverage
0.00 -8.59 -4.33 -1.46 -0.98 -1.01 -1.04 -1.11 -1.21
Leverage Ratio
0.00 8.79 4.44 2.58 2.32 2.32 2.29 2.39 2.72
Compound Leverage Factor
0.00 8.79 4.44 2.58 2.32 2.32 2.29 2.39 2.72
Debt to Total Capital
0.00% 0.00% 0.00% 28.12% 30.48% 31.05% 18.11% 30.46% 34.21%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 1.29% 2.28% 0.00% 3.79% 2.29%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 28.12% 29.19% 28.77% 18.11% 26.67% 31.92%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 159.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -59.12% 100.00% 71.88% 69.52% 68.95% 81.89% 69.54% 65.79%
Debt to EBITDA
0.00 0.00 0.00 -10.29 -7.81 -11.68 32.62 19.57 29.13
Net Debt to EBITDA
0.00 0.00 0.00 24.81 17.95 26.52 -156.26 -51.93 -70.66
Long-Term Debt to EBITDA
0.00 0.00 0.00 -10.29 -7.48 -10.83 32.62 17.14 27.18
Debt to NOPAT
0.00 0.00 0.00 -12.40 -8.00 -8.89 -7.50 -27.18 -35.71
Net Debt to NOPAT
0.00 0.00 0.00 29.89 18.37 20.17 35.91 72.11 86.63
Long-Term Debt to NOPAT
0.00 0.00 0.00 -12.40 -7.66 -8.23 -7.50 -23.80 -33.32
Altman Z-Score
0.00 0.17 2.61 2.82 1.56 0.00 0.92 0.73 0.49
Noncontrolling Interest Sharing Ratio
0.00% 159.12% 31.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 1.12 1.42 1.55 1.84 1.78 1.55 1.58 1.51
Quick Ratio
0.00 0.12 0.42 0.51 0.80 0.72 0.40 0.49 0.40
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 1,311 289 -1,856 -45 -148 32 327 238
Operating Cash Flow to CapEx
-408.41% -91.86% -36.68% 21.80% -115.71% 601.76% 1,334.28% 920.28% 679.95%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 0.07 0.08 0.06 0.08 0.11 0.14 0.15 0.16
Accounts Receivable Turnover
0.00 24.64 36.44 21.20 30.38 40.49 45.85 48.44 52.20
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 16.52 15.43 7.59 12.13 15.28 15.21 14.29 12.64
Accounts Payable Turnover
0.00 5.91 9.17 8.04 13.27 21.01 29.39 22.92 24.32
Days Sales Outstanding (DSO)
0.00 14.82 10.02 17.21 12.02 9.01 7.96 7.54 6.99
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 61.77 39.82 45.42 27.50 17.37 12.42 15.92 15.01
Cash Conversion Cycle (CCC)
0.00 -46.95 -29.80 -28.21 -15.49 -8.36 -4.46 -8.39 -8.02
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 -1,318 -1,631 145 -31 -90 -244 -634 -923
Invested Capital Turnover
0.00 -0.16 -0.11 -0.32 11.21 -17.45 -7.71 -3.33 -2.12
Increase / (Decrease) in Invested Capital
0.00 -1,318 -313 1,777 -176 -59 -154 -390 -289
Enterprise Value (EV)
0.00 -999 4,205 12,857 7,389 0.00 1,207 218 -853
Market Capitalization
216 216 6,547 15,241 11,463 0.00 5,585 4,766 3,601
Book Value per Share
$0.00 ($13.17) $9.79 $30.40 $38.78 $38.56 $38.95 $37.99 $35.45
Tangible Book Value per Share
$0.00 ($13.17) $9.79 $4.09 $11.97 $12.53 $13.72 $12.57 $9.76
Total Capital
0.00 174 711 3,519 5,817 5,926 5,048 5,629 5,367
Total Debt
0.00 0.00 0.00 989 1,773 1,840 914 1,714 1,836
Total Long-Term Debt
0.00 0.00 0.00 989 1,698 1,705 914 1,501 1,713
Net Debt
0.00 -1,492 -2,342 -2,384 -4,075 -4,176 -4,378 -4,548 -4,454
Capital Expenditures (CapEx)
2.05 4.30 12 21 16 31 21 38 61
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -1,328 -1,639 -2,093 -2,902 -2,961 -3,041 -3,399 -3,657
Debt-free Net Working Capital (DFNWC)
0.00 164 703 1,280 2,946 3,055 2,252 2,864 2,633
Net Working Capital (NWC)
0.00 164 703 1,280 2,871 2,920 2,252 2,650 2,510
Net Nonoperating Expense (NNE)
1.72 0.45 7.15 19 105 17 -93 -87 -40
Net Nonoperating Obligations (NNO)
0.00 -1,492 -2,342 -2,384 -4,075 -4,176 -4,378 -4,548 -4,454
Total Depreciation and Amortization (D&A)
2.31 1.84 0.44 43 104 65 54 57 73
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -1,225.55% -1,040.14% -878.50% -452.03% -279.78% -235.67% -232.42% -221.21%
Debt-free Net Working Capital to Revenue
0.00% 151.07% 445.81% 537.38% 458.88% 288.60% 174.53% 195.79% 159.29%
Net Working Capital to Revenue
0.00% 151.07% 445.81% 537.38% 447.18% 275.84% 174.53% 181.20% 151.84%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
($1.01) ($0.94) ($0.70) ($1.19) $0.00 ($2.11) ($0.27) $0.23 ($0.11)
Adjusted Weighted Average Basic Shares Outstanding
7.16M 7.80M 80.18M 94.78M 0.00 105.98M 106.10M 103.57M 99.92M
Adjusted Diluted Earnings per Share
($1.01) ($0.94) ($0.70) ($1.19) $0.00 ($2.11) ($0.27) ($0.07) ($0.11)
Adjusted Weighted Average Diluted Shares Outstanding
7.16M 7.80M 80.18M 94.78M 0.00 105.98M 106.10M 103.91M 99.92M
Adjusted Basic & Diluted Earnings per Share
($1.01) ($0.94) ($0.70) ($1.19) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
7.16M 7.80M 44.11M 82.81M 0.00 106.61M 106.69M 101.63M 85.28M
Normalized Net Operating Profit after Tax (NOPAT)
-5.47 -6.86 -24 -80 -222 -207 -103 -63 12
Normalized NOPAT Margin
-8.44% -6.33% -15.19% -33.48% -34.55% -19.56% -7.95% -4.31% 0.74%
Pre Tax Income Margin
-11.08% -6.89% -19.69% -58.48% -51.51% -21.06% -2.04% 2.08% -0.61%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% -39.16% -733.78% 1,806.81% -4,986.08%

Quarterly Metrics And Ratios for BILL

This table displays calculated financial ratios and metrics derived from BILL's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - 103,027,139.00 - - 98,960,440.00 99,596,727.00
DEI Adjusted Shares Outstanding
- - - - - - 103,027,139.00 - - 98,960,440.00 99,596,727.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - -0.07 - - 0.13 -0.19
Growth Metrics
- - - - - - - - - - -
Revenue Growth
22.50% 18.52% 16.11% 17.53% 13.83% 10.89% 32.10% 10.40% 14.38% 13.50% 13.78%
EBITDA Growth
71.64% 348.32% 1,002.68% -5.19% 286.53% -89.27% 24.77% -35.14% -39.59% 722.71% -41.41%
EBIT Growth
59.39% 205.17% 150.19% 0.00% 186.68% -132.00% 89.75% -127.63% -106.15% 243.50% -552.98%
NOPAT Growth
39.83% 28.06% 23.33% 0.00% 54.23% 25.79% 68.74% -115.21% 41.64% 98.30% -53.96%
Net Income Growth
57.49% 202.15% 147.85% 131.99% 183.00% -136.43% 75.76% -133.24% -107.71% 210.33% -161.27%
EPS Growth
57.78% 100.00% 364.29% 130.77% 84.21% 0.00% -33.33% -137.50% 50.00% 209.09% -950.00%
Operating Cash Flow Growth
44.27% 96.32% -2.16% 0.00% 0.00% 48.98% 6.61% 9.34% 33.79% 3.16% 32.42%
Free Cash Flow Firm Growth
186.46% 224.27% 331.79% -188.59% -79.27% -45.66% 260.29% 255.40% 649.99% 120.01% -29.26%
Invested Capital Growth
-59.00% -155.37% -170.19% 0.00% -10.57% -158.16% -159.81% 0.00% -38.82% -116.85% -45.55%
Revenue Q/Q Growth
4.43% 1.42% 6.39% 4.30% 0.00% -1.20% 7.02% 0.00% 4.78% -1.96% 7.29%
EBITDA Q/Q Growth
-51.85% 301.32% -57.79% 21.19% 0.00% -88.42% -392.08% 0.00% 92.18% 38.43% -150.21%
EBIT Q/Q Growth
-41.76% 183.03% -76.39% 34.02% 0.00% -130.65% 70.21% 0.00% 26.56% 815.15% -235.55%
NOPAT Q/Q Growth
-19.47% 42.36% 18.63% 69.67% 0.00% 6.54% 23.14% 0.00% 12.76% 97.27% -6,844.11%
Net Income Q/Q Growth
-45.08% 178.69% -76.12% 17.34% 0.00% -134.54% 38.98% 0.00% 12.63% 594.05% -244.51%
EPS Q/Q Growth
-46.15% 100.00% 0.00% -78.38% 0.00% -83.33% 118.18% 0.00% 0.00% 500.00% -241.67%
Operating Cash Flow Q/Q Growth
-10.05% -16.15% 17.68% 12.67% 0.00% 0.00% -15.79% 15.56% 8.74% -2.51% 8.10%
Free Cash Flow Firm Q/Q Growth
-69.76% 127.71% -45.35% -357.55% 0.00% 496.84% 186.32% 0.00% -68.78% 75.08% -7.94%
Invested Capital Q/Q Growth
-24.22% 76.84% -155.56% 100.00% 0.00% 45.93% -157.20% 0.00% -17.03% 15.54% -72.64%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
81.67% 82.97% 81.03% 81.95% 81.63% 81.24% 80.80% 80.54% 79.84% 81.62% 81.66%
EBITDA Margin
-6.98% 13.85% 5.49% 6.38% 11.43% 1.34% -3.66% 3.75% 6.88% 9.71% -4.55%
Operating Margin
-21.25% -8.55% -6.47% -2.15% -5.99% -8.08% -5.80% -5.24% -4.36% -0.10% -7.85%
EBIT Margin
-12.17% 9.96% 2.21% 2.84% 9.27% -2.87% -0.80% -0.71% -0.50% 3.63% -4.59%
Profit (Net Income) Margin
-12.69% 9.85% 2.21% 2.49% 9.25% -3.24% -1.84% -0.75% -0.62% 3.14% -4.24%
Tax Burden Percent
104.30% 98.85% 99.99% 87.54% 99.87% 112.56% 230.58% 105.30% 125.27% 86.54% 92.26%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 1.15% 0.01% 12.46% 0.13% 0.00% 0.00% 0.00% 0.00% 13.46% 0.00%
Return on Invested Capital (ROIC)
0.00% -272.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -274.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 271.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-1.95% -1.12% -0.70% 0.00% 0.00% 0.00% 0.59% 0.31% -0.64% 0.00% -0.30%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-1.55% 1.34% 0.30% 0.00% 0.00% 0.00% -0.12% -0.11% -0.08% 0.59% -0.75%
Return on Assets (ROA)
-1.61% 1.32% 0.30% 0.00% 0.00% 0.00% -0.28% -0.11% -0.10% 0.51% -0.69%
Return on Common Equity (ROCE)
-1.95% -1.12% -0.70% 0.00% 0.00% 0.00% 0.59% 0.31% -0.64% 0.00% -0.30%
Return on Equity Simple (ROE_SIMPLE)
-1.99% -1.29% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-47 -27 -22 -6.74 -22 -20 -16 -15 -13 -0.35 -24
NOPAT Margin
-14.87% -8.45% -6.47% -1.88% -5.98% -5.66% -4.06% -3.66% -3.05% -0.08% -5.50%
Net Nonoperating Expense Percent (NNEP)
0.16% 1.46% 0.70% 0.00% 1.28% 0.21% 0.19% 0.52% 0.23% 0.31% 0.12%
Return On Investment Capital (ROIC_SIMPLE)
-0.82% - - - -0.39% -0.36% -0.28% -0.25% -0.22% -0.01% -0.45%
Cost of Revenue to Revenue
18.33% 17.03% 18.97% 18.05% 18.37% 18.76% 19.20% 19.46% 20.16% 18.38% 18.34%
SG&A Expenses to Revenue
22.00% 25.25% 7.33% 18.63% 19.62% 20.62% 18.30% 19.44% 19.17% 17.78% 16.21%
R&D to Revenue
27.16% 25.26% 23.16% 21.95% 23.39% 24.16% 23.49% 20.29% 19.97% 18.30% 14.46%
Operating Expenses to Revenue
102.92% 91.52% 87.49% 84.10% 87.62% 89.32% 86.61% 85.78% 84.20% 81.72% 89.51%
Earnings before Interest and Taxes (EBIT)
-39 32 7.60 10 34 -10 -3.07 -2.81 -2.07 15 -20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-22 45 19 23 41 4.80 -14 15 29 39 -20
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.20 1.78 1.35 0.00 2.30 1.21 1.22 1.39 1.43 1.00 1.02
Price to Tangible Book Value (P/TBV)
7.06 5.31 3.84 0.00 7.56 3.79 3.68 4.21 4.49 3.08 3.71
Price to Revenue (P/Rev)
6.99 5.81 4.33 4.19 0.00 0.00 3.26 3.59 3.52 2.37 2.18
Price to Earnings (P/E)
0.00 0.00 0.00 712.95 0.00 0.00 200.26 451.43 0.00 23,110.88 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.14% 0.00% 0.00% 0.50% 0.22% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
3.49 2.47 0.94 0.00 0.00 0.00 0.15 0.64 0.66 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 435.92 43.06 0.00 0.00 0.00 3.57 12.06 16.80 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 7.15 55.08 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
17.54 10.95 4.33 0.00 14.39 1.62 0.62 2.67 2.65 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
130.02 23.13 37.83 0.00 0.00 0.00 0.67 2.01 8.96 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.47 0.28 0.22 0.00 0.45 0.44 0.44 0.48 0.48 0.48 0.52
Long-Term Debt to Equity
0.43 0.28 0.22 0.00 0.44 0.43 0.38 0.47 0.48 0.48 0.49
Financial Leverage
-1.08 -0.99 -1.04 0.00 -1.11 -1.04 -1.11 -1.14 -1.14 -1.10 -1.21
Leverage Ratio
2.44 2.27 2.29 0.00 2.52 2.37 2.39 2.61 2.60 2.57 2.72
Compound Leverage Factor
2.44 2.27 2.29 0.00 2.52 2.37 2.39 2.61 2.60 2.57 2.72
Debt to Total Capital
31.81% 22.02% 18.11% 0.00% 31.01% 30.68% 30.46% 32.46% 32.51% 32.55% 34.21%
Short-Term Debt to Total Capital
2.33% 0.00% 0.00% 0.00% 0.60% 0.60% 3.79% 0.58% 0.00% 0.00% 2.29%
Long-Term Debt to Total Capital
29.48% 22.02% 18.11% 0.00% 30.40% 30.08% 26.67% 31.87% 32.51% 32.55% 31.92%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
68.19% 77.98% 81.89% 0.00% 69.00% 69.32% 69.54% 67.54% 67.49% 67.45% 65.79%
Debt to EBITDA
-101.33 162.73 32.62 0.00 0.00 0.00 28.16 23.45 30.13 19.20 29.13
Net Debt to EBITDA
239.92 -589.76 -156.26 0.00 0.00 0.00 -74.71 -55.61 -72.96 -45.40 -70.66
Long-Term Debt to EBITDA
-93.90 162.73 32.62 0.00 0.00 0.00 24.65 23.03 30.13 19.20 27.18
Debt to NOPAT
-15.40 -8.47 -7.50 0.00 0.00 0.00 -27.18 -29.11 -29.11 -1,243.51 -35.71
Net Debt to NOPAT
36.46 30.70 35.91 0.00 0.00 0.00 72.11 69.01 70.49 2,939.68 86.63
Long-Term Debt to NOPAT
-14.27 -8.47 -7.50 0.00 0.00 0.00 -23.80 -28.58 -29.11 -1,243.51 -33.32
Altman Z-Score
1.18 1.15 0.93 0.00 0.00 0.00 0.72 0.79 0.78 0.63 0.49
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.69 1.63 1.55 0.00 1.66 1.69 1.58 1.67 1.65 1.66 1.51
Quick Ratio
0.63 0.48 0.40 0.00 0.54 0.55 0.49 0.54 0.52 0.50 0.40
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
106 241 132 -339 22 131 375 527 164 288 265
Operating Cash Flow to CapEx
1,557.18% 1,735.75% 1,422.47% 1,255.41% 0.00% 1,105.15% 546.50% 663.71% 742.51% 572.26% 768.76%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.13 0.13 0.14 0.00 0.00 0.00 0.15 0.15 0.16 0.16 0.16
Accounts Receivable Turnover
43.01 38.85 45.85 0.00 0.00 0.00 48.44 46.71 44.30 54.43 52.20
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
15.97 15.08 15.21 0.00 0.00 0.00 14.29 11.63 14.01 13.15 12.64
Accounts Payable Turnover
19.49 27.80 29.39 0.00 0.00 0.00 22.92 40.64 55.98 37.55 24.32
Days Sales Outstanding (DSO)
8.49 9.39 7.96 0.00 0.00 0.00 7.54 7.81 8.24 6.71 6.99
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
18.73 13.13 12.42 0.00 0.00 0.00 15.92 8.98 6.52 9.72 15.01
Cash Conversion Cycle (CCC)
-10.24 -3.73 -4.46 0.00 0.00 0.00 -8.39 -1.17 1.72 -3.01 -8.02
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-413 -96 -244 0.00 -456 -247 -634 -541 -633 -535 -923
Invested Capital Turnover
-3.71 32.27 -7.71 0.00 0.00 0.00 -3.33 -5.54 -2.85 -4.10 -2.12
Increase / (Decrease) in Invested Capital
-153 -268 -154 332 -44 -151 -390 -541 -177 -288 -289
Enterprise Value (EV)
4,346 3,071 1,207 0.00 4,502 561 218 959 1,022 -547 -853
Market Capitalization
8,710 7,225 5,585 5,629 8,767 4,678 4,766 5,383 5,463 3,790 3,601
Book Value per Share
$37.02 $38.61 $38.95 $0.00 $36.81 $37.97 $37.99 $38.20 $38.01 $38.43 $35.45
Tangible Book Value per Share
$11.56 $12.95 $13.72 $0.00 $11.21 $12.12 $12.57 $12.58 $12.16 $12.42 $9.76
Total Capital
5,795 5,205 5,048 0.00 5,521 5,584 5,629 5,748 5,640 5,638 5,367
Total Debt
1,843 1,146 914 0.00 1,712 1,713 1,714 1,866 1,834 1,835 1,836
Total Long-Term Debt
1,708 1,146 914 0.00 1,678 1,680 1,501 1,832 1,834 1,835 1,713
Net Debt
-4,364 -4,154 -4,378 0.00 -4,266 -4,117 -4,548 -4,424 -4,440 -4,338 -4,454
Capital Expenditures (CapEx)
5.12 3.85 5.53 7.06 0.00 9.01 15 15 14 18 14
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3,235 -2,899 -3,041 0.00 -3,226 -3,011 -3,399 -3,305 -3,379 -3,274 -3,657
Debt-free Net Working Capital (DFNWC)
2,973 2,402 2,252 0.00 2,751 2,820 2,864 2,985 2,895 2,898 2,633
Net Working Capital (NWC)
2,838 2,402 2,252 0.00 2,718 2,786 2,650 2,952 2,895 2,898 2,510
Net Nonoperating Expense (NNE)
-6.95 -59 -30 -16 -55 -8.67 -8.50 -12 -10 -13 -5.50
Net Nonoperating Obligations (NNO)
-4,364 -4,154 -4,378 0.00 -4,266 -4,117 -4,548 -4,424 -4,440 -4,338 -4,454
Total Depreciation and Amortization (D&A)
17 13 11 13 7.86 15 -11 18 31 25 0.20
Debt-free, Cash-free Net Working Capital to Revenue
-259.72% -233.29% -235.67% 0.00% 0.00% 0.00% -232.42% -220.33% -217.69% -204.61% -221.21%
Debt-free Net Working Capital to Revenue
238.69% 193.32% 174.53% 0.00% 0.00% 0.00% 195.79% 199.02% 186.55% 181.09% 159.29%
Net Working Capital to Revenue
227.85% 193.32% 174.53% 0.00% 0.00% 0.00% 181.20% 196.79% 186.55% 181.09% 151.84%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.38) $0.30 $0.07 $0.00 $0.33 ($0.11) ($0.07) ($0.03) ($0.03) $0.13 ($0.18)
Adjusted Weighted Average Basic Shares Outstanding
105.91M 105.44M 106.10M 0.00 103.10M 102.22M 103.57M 101.92M 100.53M 99.29M 99.92M
Adjusted Diluted Earnings per Share
($0.38) $0.00 $0.37 $0.00 ($0.06) ($0.11) $0.02 ($0.03) ($0.03) $0.12 ($0.17)
Adjusted Weighted Average Diluted Shares Outstanding
105.91M 111.18M 106.10M 0.00 104.48M 102.22M 103.91M 101.92M 100.53M 112.68M 99.92M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
105.13M 106.14M 106.69M 0.00 101.95M 103.03M 101.63M 100.16M 98.96M 99.60M 85.28M
Normalized Net Operating Profit after Tax (NOPAT)
-30 -25 -22 -6.74 -22 -20 -16 -8.29 -12 4.02 30
Normalized NOPAT Margin
-9.36% -7.81% -6.47% -1.88% -5.98% -5.66% -4.06% -2.10% -2.98% 0.99% 6.79%
Pre Tax Income Margin
-12.17% 9.96% 2.21% 2.84% 9.27% -2.87% -0.80% -0.71% -0.50% 3.63% -4.59%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-381.46% -526.36% -733.78% 2,684.00% 0.00% 0.00% 1,806.81% 2,625.95% -1,015.23% 184,548.17% -4,986.08%

Financials Breakdown Chart

Key Financial Trends

BILL Holdings has continued to grow revenue and generate operating cash flow, but profitability remains inconsistent. Revenue increased from $200.2 million in Q4 2022 to $436.2 million in Q4 2026, representing strong multi-year growth. However, the company has generally remained operating-loss-making, and Q4 2026 included a substantial restructuring charge that pushed the operating loss to $34.3 million.

Gross margin has improved over the period. Q4 2026 gross profit was $356.2 million, or approximately 81.7% of revenue, compared with roughly 78.3% in Q4 2022. This improvement suggests that BILL’s core platform can scale efficiently, although high sales, marketing, research and development costs continue to absorb gross profit.

  • Revenue growth remains strong: Q4 revenue rose 7.3% sequentially from $406.6 million in Q3 2026 and was more than double the $200.2 million reported in Q4 2022.
  • Gross margin has expanded: Q4 2026 gross margin was approximately 81.7%, up from about 78.3% in Q4 2022, indicating improving economics at the gross-profit level.
  • Operating cash flow has remained consistently positive: BILL generated $111.0 million of operating cash flow in Q4 2026, following $102.7 million in Q3, $105.3 million in Q2 and $96.9 million in Q1.
  • Liquidity is substantial: At March 31, 2026, cash and equivalents, restricted cash and short-term investments totaled approximately $6.2 billion. Much of this balance is associated with customer deposits, but it provides an important liquidity cushion.
  • Share repurchases have reduced the share base: BILL repurchased $287.8 million of common stock in Q4 2026 after repurchasing $56.9 million in Q3 and $132.7 million in Q2. Basic weighted-average shares declined to approximately 99.9 million in Q4 from 103.6 million in Q4 2025.
  • Short-term debt has been eliminated: The March 2026 balance sheet showed no short-term debt, while long-term debt was relatively stable at approximately $1.83 billion during fiscal 2026.
  • Cash flow is heavily influenced by non-cash items and customer funds: Q4 operating cash flow exceeded net income despite an $18.5 million net loss, primarily because of $60.1 million in non-cash adjustments and a $43.2 million benefit from operating assets and liabilities.
  • Investment activity creates large quarter-to-quarter swings: Purchases, maturities and other investing activities produced net investing cash inflows of $244.5 million in Q4 2026, compared with a $301.0 million outflow in Q3. These movements appear tied largely to managing the company’s investment portfolio and customer funds rather than to recurring operating performance.
  • Operating profitability remains weak: BILL reported operating losses in each fiscal 2026 quarter, including a $34.3 million loss in Q4. Even excluding the $76.6 million restructuring charge, the company would still have recorded a meaningful underlying operating loss.
  • Net income has deteriorated again: Q4 2026 net loss was $18.5 million, reversing Q3’s $12.8 million profit. The company has reported net losses in three of the four fiscal 2026 quarters, and retained earnings remained negative at approximately $1.77 billion as of March 31, 2026.
  • Operating expenses remain high relative to revenue: Q4 marketing expense was $158.3 million, research and development expense was $63.1 million and selling, general and administrative expense was $70.7 million. These costs leave limited room for operating profit despite the company’s high gross margin.
  • Restructuring costs add execution risk: The $76.6 million Q4 restructuring charge was materially higher than the charges recorded in earlier fiscal 2026 quarters, raising questions about the scale and duration of BILL’s cost-reduction efforts.
  • Long-term debt is material: Long-term debt of approximately $1.83 billion represents a significant obligation relative to the company’s recurring operating earnings, which are currently negative.

Overall, the statements show a company with attractive revenue growth, improving gross margins, strong reported operating cash flow and considerable liquidity. The main concern for investors is whether BILL can convert that growth into sustainable operating and net profitability without relying on interest income, restructuring adjustments or volatile investment activity. The Q4 2026 results suggest that the path to consistent earnings remains incomplete.

09/07/26 12:09 AM ETAI Generated. May Contain Errors.

BILL Financials - Frequently Asked Questions

According to the most recent income statement we have on file, BILL's financial year ends in June. Their financial year 2026 ended on June 30, 2026.

BILL's net income were at -$11.24 million at the end of 2026, a 147.2% decrease from 2025, and a 56.2% increase since 2018. View BILL's forecast to see where analysts expect BILL to go next.

BILL's total operating income in 2026 was -$73.45 million, based on the following breakdown:
  • Total Gross Profit: $1.34 billion
  • Total Operating Expenses: $1.41 billion

Over the last 8 years, BILL's total revenue changed from $64.87 million in 2018 to $1.65 billion in 2026, a change of 2,448.6%.

BILL's total liabilities were at $6.69 billion at the end of 2026, a 8.7% increase from 2025, and a 394.4% increase since 2019.

In the past 7 years, BILL's cash and equivalents has ranged from $90.31 million in 2019 to $1.62 billion in 2023, and is currently $1.03 billion as of their latest financial filing in 2026.

Over the last 8 years, BILL's book value per share changed from 0.00 in 2018 to 35.45 in 2026, a change of 3,544.9%.



Financial statements for NYSE:BILL last updated on 8/20/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners